Biopetrolia is exploring their technology platform for engineering of yeast to substantially increase the yield of fatty acyl-CoA for potential use in the production of biofuels, food ingredients and cosmetics.
Microfibrillar-associated protein 4 (MFAP4) has been identified as a potential new target for treatment of age-related macular degeneration (AMD). The DARE project develops and validate an anti MFAP4 antibody. The project is based at University of Southern Denmark.
ISD-Immunotech originates at Aarhus University and will focus on Systemic Lupus Erythematosus (SLE). SLE is affecting more than 3M individuals per year and is a prototypic autoimmune disease, and orphan drug designation, that is characterized by systemic chronic inflammation affecting multiple major organ systems.
Despite recent clinical advances in oncology, breast cancer remains one of the leading causes of cancer-related deaths in women.
Janine Erler, a world-leading scientist in the field of hypoxia-induced metastasis, identified the tumor secreted lysyl oxidase (LOX), a collagen cross-linking HIF-inducible enzyme, to be clinically correlated with metastasis.
miRana is developing microRna therapeutics for the treatment of hematologic malignancies (AML and MDS) and myeloma bone disease (Lytic bone disease). The project is based at Aalborg University, Dept of Clinical Medicine.